Content about treatment for prostate cancer

March 11, 2011

The Food and Drug Administration has approved biotech company Dendreon’s expansion of manufacturing capacity for an immunotherapy treatment for prostate cancer, Dendreon said Thursday.

© 2014 Drug Store News. All Rights Reserved.